By stimulating both the PKG and PI3K/Akt pathways, PDE5 inhibitors present a synergistic therapeutic strategy to protect neurons, minimize cell death, and improve recovery outcomes in stroke [28]. This evidence concerns the gene PRKG1 and Stroke.